Bio Green Med Solution, Inc. has 21 Schedule 13D or 13G filings on record since 2025-08-04. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Doris Wong Sing Ee | 20.58% | 1,111,131 | SCHEDULE 13D/A, 2025-11-13 | 2025-11-12 |
| Lazar David E. | 0% | 0 | SCHEDULE 13D/A, 2025-08-08 | 2025-08-05 |
| Armistice Capital, LLC | 0% | 0 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| Kua Khai Loon | 0% | 0 | SCHEDULE 13G/A, 2026-03-13 | 2025-12-31 |
| Ong Yee Lung | 0% | 0 | SCHEDULE 13G/A, 2026-03-13 | 2025-12-31 |
| Yap Kim Choy | 0% | 0 | SCHEDULE 13G/A, 2026-08-12 | 2026-06-30 |
| FITTERS Diversified Berhad | 0% | 0 | SCHEDULE 13G/A, 2026-08-12 | 2026-06-30 |
Purpose of Transaction (Item 4)
Doris Wong Sing Ee
Datuk Dr. Doris Wong Sing Ee purchased the shares pursuant to the Securities Purchase Agreement. In connection with the purchase, Datuk Dr. Doris Wong Sing Ee was appointed as Chief Executive Office and as an Executive Director of the Issuer. Subject to ongoing evaluation, except as set forth above, the Reporting Person has no current plans or proposals which relate to or would result in any of the following: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization, or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure, including but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940; (g) Changes in the Issuer's charter, bylaws, or instruments corresponding thereto or other actions which may impede …The first part of Item 4 of the SCHEDULE 13D/A filed 2025-11-13; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-04 | Lazar David E. | 8.18% | SCHEDULE 13D/A |
| 2025-08-08 | Lazar David E. | 0% | SCHEDULE 13D/A |
| 2025-08-14 | Armistice Capital, LLC | 0% | SCHEDULE 13G/A |
| 2025-08-18 | Kua Khai Loon | 9.8% | SCHEDULE 13G |
| 2025-08-18 | Ong Yee Lung | 9.8% | SCHEDULE 13G |
| 2025-08-18 | Yap Kim Choy | 9.8% | SCHEDULE 13G |
| 2025-09-02 | Yap Kim Choy | 20.76% | SCHEDULE 13G/A |
| 2025-09-02 | Kua Khai Loon | 20.76% | SCHEDULE 13G/A |
| 2025-09-02 | Ong Yee Lung | 20.76% | SCHEDULE 13G/A |
| 2025-09-16 | FITTERS Diversified Berhad | 19.99% | SCHEDULE 13G |
| 2025-10-10 | Kua Khai Loon | 16.35% | SCHEDULE 13G/A |
| 2025-10-14 | FITTERS Diversified Berhad | 14.46% | SCHEDULE 13G/A |
| 2025-10-23 | FITTERS Diversified Berhad | 7.98% | SCHEDULE 13G/A |
| 2025-10-31 | Yap Kim Choy | 14.82% | SCHEDULE 13G/A |
| 2025-11-03 | Ong Yee Lung | 11.79% | SCHEDULE 13G/A |
| 2025-11-13 | Doris Wong Sing Ee | 20.58% | SCHEDULE 13D/A |
| 2026-03-13 | Kua Khai Loon | 0% | SCHEDULE 13G/A |
| 2026-03-13 | Ong Yee Lung | 0% | SCHEDULE 13G/A |
| 2026-05-12 | Yap Kim Choy | 8.47% | SCHEDULE 13G/A |
| 2026-08-12 | Yap Kim Choy | 0% | SCHEDULE 13G/A |
| 2026-08-12 | FITTERS Diversified Berhad | 0% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Bio Green Med Solution, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.